Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored

Title: Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored
Authors: Edit Mikó; Tünde Kovács; Éva Sebő; Judit Tóth; Tamás Csonka; Gyula Ujlaki; Adrienn Sipos; Judit Szabó; Gábor Méhes; Péter Bai
Source: Cells, Vol 8, Iss 4, p 293 (2019)
Publisher Information: MDPI AG
Publication Year: 2019
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: breast cancer; microbiome; estrogen deconjugation; lithocholic acid; secondary bile acids; cadaverine; TGR5; FFAR; TAAR; mitochondrial metabolism; OXPHOS; Cytology; QH573-671
Description: Breast cancer is a leading cause of death among women worldwide. Dysbiosis, an aberrant composition of the microbiome, characterizes breast cancer. In this review we discuss the changes to the metabolism of breast cancer cells, as well as the composition of the breast and gut microbiome in breast cancer. The role of the breast microbiome in breast cancer is unresolved, nevertheless it seems that the gut microbiome does have a role in the pathology of the disease. The gut microbiome secretes bioactive metabolites (reactivated estrogens, short chain fatty acids, amino acid metabolites, or secondary bile acids) that modulate breast cancer. We highlight the bacterial species or taxonomical units that generate these metabolites, we show their mode of action, and discuss how the metabolites affect mitochondrial metabolism and other molecular events in breast cancer. These metabolites resemble human hormones, as they are produced in a “gland„ (in this case, the microbiome) and they are subsequently transferred to distant sites of action through the circulation. These metabolites appear to be important constituents of the tumor microenvironment. Finally, we discuss how bacterial dysbiosis interferes with breast cancer treatment through interfering with chemotherapeutic drug metabolism and availability.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/2073-4409/8/4/293; https://doaj.org/toc/2073-4409; https://doaj.org/article/e95c89d215a54fce8bb4d62f4c256136
DOI: 10.3390/cells8040293
Availability: https://doi.org/10.3390/cells8040293; https://doaj.org/article/e95c89d215a54fce8bb4d62f4c256136
Accession Number: edsbas.800346FE
Database: BASE